1upHealth's New Payer Product Surfaces $1M Compliance Risk in FHIR Data Pipelines

1upHealth shifts payer interoperability spend from interfaces to APIs

1upHealth launched 1up Clinical Connect on September 1, 2026, a product that lets health plans automatically acquire clinical data from provider EHRs—including Epic and athenahealth—via FHIR APIs and combine it with claims data into a single longitudinal member record. The product uses USCDI-standard clinical data and targets provider systems that have implemented ONC g(10) patient access endpoints.

For payer CIOs and interoperability architects, this creates a clearer build-versus-buy decision. Rather than building direct FHIR connectivity and USCDI data pipelines to each EHR, payers can outsource the connectivity and normalization. That shifts spend from one-off interface projects—typically billed as professional services—to platform or API subscriptions. Because the product is explicitly USCDI- and FHIR-based, it can reuse data pipelines across HEDIS, Stars, risk adjustment, care management, and prior authorization programs, potentially consolidating multiple vendor contracts over two to three years.

1up Clinical Connect competes directly with Inovalon (clinical data extraction and risk analytics), Veradigm (payer–provider data exchange), Change Healthcare/Optum (claims plus clinical aggregation), and health information networks that sell connectivity plus normalization. Unlike legacy network-driven offerings, 1up leans heavily on FHIR APIs rather than document-level CCDs or HL7 v2 interfaces. This positions it against other FHIR-native platforms and TEFCA-based exchange services that still rely on older standards.

The $1M penalty for mishandling FHIR data

Standardized FHIR plus USCDI data reduces data quality and mapping risk, but it increases regulatory exposure. Payers are now directly managing large volumes of clinical data that must comply with ONC and CMS information blocking rules, patient access requirements, and algorithm transparency mandates under HTI-1. Information blocking violations carry penalties up to $1 million per violation for vendors and networks.

When payers use aggregated clinical data for decision support—particularly AI-powered models for prior authorization or care management—they trigger HTI-1 transparency requirements. Buyers need to evaluate business associate agreement terms, data provenance, and auditability of the longitudinal records. If a payer uses FHIR-sourced clinical data in an algorithm that denies or delays care, and that algorithm is not disclosed or is used in a way that blocks information flow, the payer and the vendor both carry compliance risk.

This is not theoretical. ONC's information blocking rules, which became enforceable for certified health IT in 2021 and expanded under HTI-1, explicitly target actors that use interoperability infrastructure to restrict data access. The combination of FHIR APIs, USCDI data, and automated decision support creates a compliance surface area that most payer legal and privacy teams have not yet fully scoped.

USCDI v7 adds 29 data elements and resets vendor baselines

ONC released draft USCDI v7 on January 29, 2026, proposing 29 new data elements and one significantly revised element, with final release targeted for July 2026. USCDI v3 became required for certified health IT on January 1, 2026, adding new required classes including health insurance information, clinical tests, functional status, disability status, and social determinants of health. USCDI v7 expands the scope further, particularly around population health, equity, and care coordination.

For buyers, USCDI version changes reset the baseline for what EHR vendors, interoperability platforms, and analytics tools must support. Products like 1up Clinical Connect that explicitly align to USCDI standards will need to update data models and APIs each year. Buyers should confirm how vendors handle USCDI version transitions—whether they auto-update, require migration projects, or charge separately for new data elements. Vendors that lag behind the annual USCDI cadence create integration debt.

The federal Interoperability Framework from CMS, ASTP, and ONC was updated as a voluntary blueprint for modern health data exchange, but USCDI requirements are not voluntary for certified health IT. Payers and health systems using FHIR-based interoperability products must plan for annual USCDI updates starting in January (draft) and July (final) each year.

What to watch

Pricing and adoption numbers for 1up Clinical Connect are not yet public. Buyers evaluating similar FHIR-based aggregation products should request specific per-member or per-API-call pricing, data latency guarantees, and failure handling for EHR API downtime. The product's value depends on EHR API availability, which varies widely across Epic, athenahealth, and other systems.

More importantly, payers should audit how clinical data acquired via FHIR APIs is used in automated decision support, particularly for prior authorization, utilization management, and care management algorithms. If those algorithms fall under HTI-1 transparency requirements, payers need documentation of data sources, decision logic, and access controls. The risk is not just regulatory—it is reputational. A $1 million penalty for information blocking is small compared to the cost of a public enforcement action that questions a payer's use of clinical data in coverage decisions.

USCDI v7's final release in July 2026 will clarify which new data elements are required and on what timeline. Buyers should confirm vendor roadmaps for USCDI v7 support now, before budget cycles close for 2027.